Logo Logo
Contact Us
Banner

Sacituzumab govitecan

Products

Quote Request

Sacituzumab govitecan

Sacituzumab govitecan

Catalog No.: PC0146

Size: 1 mg, 5 mg,10 mg, 50 mg

Description

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.

Molecular Weight 160 KDa (Approximately)
CAS No. 1491917-83-9
Appearance Solid
Color White to off-white
Shipping Room temperature in continental US; may vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
In Vivo Sacituzumab govitecan (IMMU-132) (17.5 mg/kg; twice weekly for 4 weeks) produces significant antitumor effects in mice bearing human gastric cancer xenografts.
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Logo

As science and technology continue to evolve, Alfa Cytology, as a provider of preclinical research services, is committed to maintaining the pace of progress, providing pancreatic cancer-related solutions that leverage existing resources to help our customers accelerate research and development.

By Molecule Type

By Research Phase

Company

Copyright © Alfa Cytology. All rights reserved.